A meeting was recently held in Beijing for the inspection and acceptance of the “cultivation and enhancement of vertical integration capability for the internationalization of chemical preparations” project undertaken by China Resources Saike Pharmaceutical Co., Ltd. (CR Saike). The expert panel carefully listened to CR Saike’s project report, reviewed relevant materials, conducted field inspection of project progress after the meeting, and eventually accepted the project.

This capability enhancement project by CR Saike was approved by the National Development and Reform Commission (NDRC), Ministry of Finance, Ministry of Health and Ministry of Industry and Information Technology in 2012. Implementing the project of preparation internationalization has twofold purposes. On the one hand, it is to align the company’s internal quality system with international quality standards such as those in the US and EU, improve the capability of quality management and risk control, and raise the overall level of domestic pharmaceutical industry. On the other hand, it is to form competitive edges on the vertical value chain integrating R&D, registration, production and sale. The project will not only boost the company’s economic benefits, but also promote the international certification of preparation producers, effectively improve drug quality and lower its cost, advance industrial restructuring and technical upgrade, and achieve energy conservation and emission reduction in production.